The
global
ventricular assist devices market is expected to grow at a CAGR of
11.61% during the forecast period. Major vendors in the global ventricular
assist devices market include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp.,
Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co.
KGaA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk
Innovative Technology Inc., among others.
Vendors are focusing on increasing the
number of product launches to strengthen their position in the market. For
instance, Abbott Laboratories, in August 2017, the company launched HeartMate 3 Left
Ventricular Assist System. This helped the physicians for managing advanced
heart failure patients in need of short-term hemodynamic support. Abiomed Inc., in August
2019, the company launched Impella CP with SmartAssist technology,
which is designed to improve patient outcomes with advanced algorithms and
simplified patient management in Europe.
Similarly, LivaNova Plc, in July 2019,
the company launched Bi-Flow, an innovative arterial femoral cannula to prevent
limb ischemia during cardiac surgery. Medtronic Plc, in October 2019, the company launched the GI Genius
intelligent endoscopy module in Spain. Hence, the increasing number of product
launches by vendors is expected to boost the growth of the global ventricular
assist devices market during the forecast period.
Browse Full Report
- http://bit.ly/2RnTgy0
No comments:
Post a Comment